Inventor · disambiguated record
Wei Qi
Also filed as: QI WEI · QI WEI (VICKY) · QI WEI W
11 granted patents·9 pending applications·31 citations·filing 2005–2025
86Inventor score
Files withNOVARTIS AG8SICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD3CHAN HO MAN2QINGDAO KINGAGROOT CHEMICAL COMPOUND CO LTD2SHANGHAI UNICAR-THERAPY BIO-MEDICINE TECH CO LTD2
Top patents by PatentIndex Score
20 records- 0193US11207325B2Triazolopyrimidine compounds and uses thereofNOVARTIS AG·Filed 2020·Granted Dec 28, 2021·3 cites·19 claims
- 0289US9580437B2Triazolopyrimidine compounds and uses thereofCHAN HO MAN·Filed 2015·Granted Feb 28, 2017·15 cites·20 claims
- 0387US10159662B2Azetidine derivative, preparation method therefor, and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2016·Granted Dec 25, 2018·4 cites·33 claims
- 0481US10689378B2Triazolopyridine compounds and uses thereofNOVARTIS AG·Filed 2017·Granted Jun 23, 2020·4 cites·18 claims
- 0581US10220036B2Triazolopyrimidine compounds and uses thereofNOVARTIS AG·Filed 2015·Granted Mar 5, 2019·3 cites·26 claims
- 0679US10676479B2Imidazolepyridine compounds and uses thereofNOVARTIS AG·Filed 2017·Granted Jun 9, 2020·2 cites·10 claims
- 0775US11931363B2Triazolopyrimidine compounds and uses thereofNOVARTIS AG·Filed 2021·Granted Mar 19, 2024·0 cites·22 claims
- 0865US2024216378A1Triazolopyrimidine compounds and uses thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0963US11045455B2Azetidine derivative, preparation method therefor, and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2020·Granted Jun 29, 2021·0 cites·15 claims
- 1062US2019060291A1Azetidine derivative, preparation method therefor, and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 1162US2019142837A1Triazolopyrimidine compounds and uses thereofNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1251US12473273B2Quinoline compounds and compositions for inhibiting EZH2NOVARTIS AG·Filed 2021·Granted Nov 18, 2025·0 cites·19 claims
- 1351US2024043859A1Herbicide-resistant protein, and gene and use thereofQINGDAO KINGAGROOT CHEMICAL COMPOUND CO LTD·Filed 2021·Application pending·0 cites
- 1448US2023287389A1A method for generating new mutation in organism and use thereofQINGDAO KINGAGROOT CHEMICAL COMPOUND CO LTD·Filed 2020·Application pending·0 cites
- 1547US2025154478A1ISPETASE-8xCHIMERA RECOMBINASE, ENCODING GENE, RECOMBINANT PLASMID, ENGINEERED STRAIN AND APPLICATIONSBEIJING MEIHAO BIOTECHNOLOGY CO LTD·Filed 2025·Application pending·0 cites
- 1642US11098123B2OCTS technology-based pancreatic cancer and malignant mesothelioma CAR-T therapeutic vector, construction method therefor, and use thereofSHANGHAI UNICAR THERAPY BIO MEDICINE TECH CO LTD·Filed 2017·Granted Aug 24, 2021·0 cites·20 claims
- 1742US10934357B2Malignant glioma CAR-T therapeutic vector based on OCTS technology, and construction method and application thereofSHANGHAI UNICAR THERAPY BIO MEDICINE TECH CO LTD·Filed 2017·Granted Mar 2, 2021·0 cites·13 claims
- 1837US2016091485A1Markers for ezh2 inhibitorsCHAN HO MAN·Filed 2014·Application pending·0 cites
- 1931US2006257421A1Pneumolysin derivativesOCHS MARTINA·Filed 2005·Application pending·0 cites
- 2029US2007254847A1Pharmaceutical Composition Containing Steroidal Saponins, the Preparation Method and Use ThereofCHENGDU DI AO PHARMACEUTICAL G·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wei Qi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →